Glypican-3-targeted therapy in hepatocellular carcinoma: biological insights and therapeutic strategies
{{output}}
Glypican-3 (GPC3) is an oncofetal cell surface proteoglycan that is highly expressed in hepatocellular carcinoma (HCC) and largely absent from normal adult tissues, making it an attractive target for gene and cell therapies. A broad range of GPC3-directed stra... ...